Catalyst Capital Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-8,200
Closed -$366K 546
2016
Q3
$366K Buy
+8,200
New +$356K 0.04% 221

Other funds holding SYNH

Catalyst Capital Advisors's SYNH Position: Q4 2016 in Review

Catalyst Capital Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2016, closing a stake of 8,200 shares — an estimated $366K sold.

Catalyst Capital Advisors first reported a position in SYNH in Q3 2016 and held it in 1 quarter. The position peaked at $366K in Q3 2016. 245 funds tracked by Wall St. Rank hold SYNH as of Q4 2016.

  • Catalyst Capital Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2016 after selling out during the quarter.
  • Catalyst Capital Advisors sold 8,200 Syneos Health, Inc. Class A Common Stock shares in Q4 2016, an estimated $366K.
  • Catalyst Capital Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2016 and held it in 1 quarter.
  • Catalyst Capital Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $366K in Q3 2016.
  • 245 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2016.

Based on Catalyst Capital Advisors's 13F filing for Q4 2016, filed 8 Feb 2017.